KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma
STOCKHOLM & LONDON–(BUSINESS WIRE)–Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for …